07/26/2026
Nobody tells you this part.
You start hormone therapy expecting a before-and-after. What most women get is a series of adjustments. You try something. You come back. You describe what changed. The plan gets refined.
Three steps forward, one step back, then three more.
That isn't a sign something's wrong: 𝗶𝘁'𝘀 𝗽𝗲𝗿𝗶𝗺𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗲. Your estradiol isn't declining in a straight line, it's swinging. The prescription that fit you in March may not fit in September, because you aren't the same hormonal picture you were in March. The dose follows the body, not the calendar.
In my practice, about 30% of women feel great from the first plan. That's lucky, and it isn't always a reflection of how healthy anyone was going in. For everyone else, the first plan is a starting point, not a verdict.
If an adjustment makes you feel worse, that's not a wasted month. It's information: how your body handles that route, that dose, that timing. Something no lab value alone would have shown me.
Which is why who you do this with matters more than what you start on. Frequent titration is only safe when you can reach your provider, and only productive when that provider knows this stage of life deeply.
The long game: Right now, we're managing symptoms. Over the next thirty years we're protecting bone density, lean muscle, and urogenital tissue. Those decide whether you're strong and independent at 80.
Symptom relief is why women start. Longevity is why we keep going.